In addition, the overexpression of SREBP1 has been detected in several cancers, such as the liver, breast, prostate, and bladder; therefore, the up-regulated expression of FAS in tumor cells is considered to be related to the overexpression of SREBP1 [11–14]. Here, SREBF1 is linked to cancer.